MR
Marker Therapeutics
MRKR·NASDAQHouston TXFounded 201820 employees
Micro CapbiotechPublicOncology
Platform: MultiTAA T
Market Cap
$0.02B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (MRKR)
Loading MRKR stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Teralucimab | MRK-9763 | Approved | 1 | SMN2 | MDDADPKD | ||
| MRK-3812 | MRK-3812 | Phase 3 | 4 | CD3 | WMPSP |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)